跳至主要内容
临床试验/TCTR20141119001
TCTR20141119001Enrolling By Invitation2 期

The effects of active hexose correlated compound (AHCC) on level of CD4+ and CD8+ in epithelial ovarian cancer patients receiving platinum based chemotherapy

Ratchadapiseksompotch foundation0 个研究点目标入组 40 人开始时间: 2014年11月19日最近更新:
适应症

试验速览

阶段
2 期
状态
Enrolling By Invitation
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 70 Years(—)
性别
Female

入选标准

  • - First line chemotherapy
  • - Age between 20-70 years
  • - No underlying disease such as HIV infection SLE, leukemia ( low immune )
  • - Liver function within normal limit
  • - Kidney function within normal limit
  • - No steroid used

排除标准

  • - History of radiation before or at time of receiving chemotherapy
  • - ECOG performance status more than 2
  • - Bone marrow metastasis

研究者

发起方
Ratchadapiseksompotch foundation

相似试验

The effects of active hexose correlated compound... | 临床试验